Isolog schools

Competition Bureau reaches agreement with Isologic to protect competition in healthcare

Retrieved on: 
Friday, March 24, 2023
Commissioner, Competition Tribunal, Radiopharmaceutical, SPECT, Competition Bureau, Competition, The Competition Act, 2002, QC, Competition Act, News, Medical imaging, Bureau, Isolog schools

GATINEAU, QC, March 24, 2023 /CNW/ - The Competition Bureau announced today that it has entered into a consent agreement with Isologic Innovative Radiopharmaceuticals Inc. (Isologic) to address competition concerns with its contracting practices in the radiopharmaceutical industry.

Key Points: 
  • GATINEAU, QC, March 24, 2023 /CNW/ - The Competition Bureau announced today that it has entered into a consent agreement with Isologic Innovative Radiopharmaceuticals Inc. (Isologic) to address competition concerns with its contracting practices in the radiopharmaceutical industry.
  • A Bureau investigation found that Isologic's contractual practices with certain customers contravened the abuse of dominance provisions of the Competition Act.
  • Isologic cooperated with the Bureau's investigation and agreed to resolve the Bureau's competition concerns by entering into a consent agreement.
  • Promoting and protecting competition and innovation in the Canadian health care sector is a key priority for the Competition Bureau.

Isologic Launches Illuccix® PSMA PET Imaging Agent to Detect Prostate Cancer

Retrieved on: 
Thursday, March 16, 2023
Health Canada, Cancer, Physician, Health, Prostate cancer, Hope, PSMA, Patient, Medical imaging, Isolog schools

MONTREAL, March 16, 2023 /CNW/ - Isologic Innovative Radiopharmaceuticals is proud to announce that the prostate cancer imaging agent Illuccix®, Ga 68 Gozetotide Preparation Kit, also known as PSMA-11, is now available in Canada.

Key Points: 
  • MONTREAL, March 16, 2023 /CNW/ - Isologic Innovative Radiopharmaceuticals is proud to announce that the prostate cancer imaging agent Illuccix®, Ga 68 Gozetotide Preparation Kit, also known as PSMA-11, is now available in Canada.
  • 24,000 men are diagnosed with prostate cancer each year in Canada, making it the number one cancer among men.
  • "Health Canada has approved Illuccix®, providing Canadian physicians with a new diagnostic tool" states André Gagnon, president of Isologic.
  • "Illuccix® is a valuable tool to help physicians detect metastatic prostate cancer and guide patient management decisions.

Global $1+ Bn Drone Detection Optical Systems Markets, 2017-2020 & 2021-2027 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, August 31, 2021
Technology, Security, Other Technology, Isolog schools, CAGR, Transport, Adoption, Estimation, Equipment, Government, Component, Data, Hardware, Investment, Hacking, Airport, Education, Restaurant, IEEE 802.11ax-2021, COVID-19, USD, Health, Video game, Vaccine

The global drone detection optical systems market held a market value of USD 166.8 Million in 2020 and is forecasted to reach USD 1,039.2 Million by the year 2027.

Key Points: 
  • The global drone detection optical systems market held a market value of USD 166.8 Million in 2020 and is forecasted to reach USD 1,039.2 Million by the year 2027.
  • These threats are expected to increase the demand for drone detection optical systems, hence boosting the market growth.
  • All these applications are increasing the demand for drone detection optical systems, hence boosting the market growth.
  • The hardware segment is expected to grow owing to its high demand for manufacturing of the drone detection optical systems.